SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-282253
Filing Date
2023-11-22
Accepted
2023-11-22 16:16:55
Documents
1
Group Members
COLUMN GROUP II GP, LPDAVID GOEDDELPETER SVENNILSON

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d821190dsc13da.htm SC 13D/A 77152
  Complete submission text file 0001193125-23-282253.txt   78873
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 4158652050
COLUMN GROUP II, LP (Filed by) CIK: 0001600420 (see all company filings)

IRS No.: 211417046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Subject) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91982 | Film No.: 231433702
SIC: 2834 Pharmaceutical Preparations